P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIA
Main Authors: | Jochen Greiner, Patrick Schuler, Hubert Schrezenmeier, Susanne Hofmann, Marlies Götz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000968816.72631.a8 |
Similar Items
-
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
by: Barbara Depreter, et al.
Published: (2020-05-01) -
Leukemic stem cells and therapy resistance in acute myeloid leukemia
by: Patrick Stelmach, et al.
Published: (2023-02-01) -
Characterising the cell biology of leukemic stem cells in acute myeloid leukemia.
by: Cornforth, TV
Published: (2013) -
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
by: Craddock, C, et al.
Published: (2013) -
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia.
by: Craddock, C, et al.
Published: (2013)